247 related articles for article (PubMed ID: 16897646)
1. [Prostatic punch biopsy].
Braun M; Engelmann U
Aktuelle Urol; 2006 Jul; 37(4):291-302. PubMed ID: 16897646
[No Abstract] [Full Text] [Related]
2. The prostate biopsy.
Harv Mens Health Watch; 2003 Jul; 7(12):4-7. PubMed ID: 12888462
[No Abstract] [Full Text] [Related]
3. [Screening for prostatic cancer].
Pushkar' DIu; Govorov AV; Bormotin AV
Urologiia; 2003; (1):10-5. PubMed ID: 12621959
[TBL] [Abstract][Full Text] [Related]
4. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
Stamey TA
BJU Int; 2004 Nov; 94(7):963-4. PubMed ID: 15541106
[No Abstract] [Full Text] [Related]
5. PSA scores: should we use a lower threshold?
Carter HB
Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
[No Abstract] [Full Text] [Related]
6. PSA: the plot thickens.
Health News; 2003 Oct; 9(10):15. PubMed ID: 14619777
[No Abstract] [Full Text] [Related]
7. Verification bias and the prostate-specific antigen test--is there a case for a lower threshold for biopsy?
Schröder FH; Kranse R
N Engl J Med; 2003 Jul; 349(4):393-5. PubMed ID: 12878747
[No Abstract] [Full Text] [Related]
8. Prostate biopsy and what men should be told about the procedure.
Eke U; Eke F
Saudi J Kidney Dis Transpl; 2009 May; 20(3):484-5. PubMed ID: 19414960
[No Abstract] [Full Text] [Related]
9. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
Philip J
Eur Urol; 2008 May; 53(5):981-2. PubMed ID: 17997013
[No Abstract] [Full Text] [Related]
10. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
Patel A
Eur Urol; 2008 May; 53(5):982-3. PubMed ID: 17997023
[No Abstract] [Full Text] [Related]
11. Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy.
Stephan C; Lein M; Schnorr D; Loening SA; Jung K
BJU Int; 2004 Jun; 93(9):1360-1. PubMed ID: 15180645
[No Abstract] [Full Text] [Related]
12. Predicting the risk of prostate cancer on biopsy.
Ebell MH
Am Fam Physician; 2005 Sep; 72(6):1091-2. PubMed ID: 16190507
[No Abstract] [Full Text] [Related]
13. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
14. Patients' perceptions of transrectal prostate biopsy: a qualitative study.
Chapple AB; Ziebland S; Brewster S; McPherson A
Eur J Cancer Care (Engl); 2007 May; 16(3):215-21. PubMed ID: 17508940
[TBL] [Abstract][Full Text] [Related]
15. A model to explain the 'vanishing' prostate -- the curative biopsy theory.
Kommu S
BJU Int; 2004 Oct; 94(6):939-40. PubMed ID: 15476547
[No Abstract] [Full Text] [Related]
16. Editorial comment on: decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
Finney Rutten LJ
Eur Urol; 2008 Jun; 53(6):1193. PubMed ID: 17709172
[No Abstract] [Full Text] [Related]
17. [Diagnostic possibilities of prostate biopsy].
Pushkar' DIu; Govorov AV
Urologiia; 2002; (6):46-51. PubMed ID: 12577581
[No Abstract] [Full Text] [Related]
18. [Elevated PSA--what to do?].
Machemer H; Rohde D
MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
[No Abstract] [Full Text] [Related]
19. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
20. Easing fears about undergoing prostate biopsy.
Johns Hopkins Med Lett Health After 50; 2001 Aug; 13(6):3. PubMed ID: 14723196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
